Pancreatic Cancer Research

ResearcherThird Affiliated Hospital of Guangzhou Medical UniversityNo recent work listed

Jiao Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-2874-0354; OpenAlex author ID A5100349708. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. EP300 promotes ferroptosis via HSPA5 acetylation in pancreatic cancer. Last author DOI 10.1038/s41598-023-42136-8↗
  2. MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells. First author DOI 10.1016/j.chembiol.2021.01.006↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rui Kang · 2 shared papers, 2021–2023 · strength 0.39
  2. Daolin Tang · 2 shared papers, 2021–2023 · strength 0.39
  3. Yuan Wang · 1 shared paper, 2023 · strength 0.22
  4. Yangchun Xie · 1 shared paper, 2021 · strength 0.17
  5. Feimei Kuang · 1 shared paper, 2021 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.